CME Accreditation

Accreditation:This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Florida College of Medicine and Cedars Sinai. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit: The University of Florida College of Medicine designates this live activity for a maximum of 24.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note: The maximum number of 24.25 AMA PRA Category 1 Credits™  includes 17.00 plus the additional credits offered in the optional Pre-Symposium Workshops.

Objectives: Upon completion of this course, participants should be able to:

  • Review the range and safety of fertility preservation techniques and technologies available to breast cancer patients and survivors
  • Identify the manifestations of menopause in breast cancer survivors as well as the efficacy and safety of various interventions, including hormones, hormonal analogues and manipulators and alternative therapies
  • Assess the available approaches and treatments in managing post-operative pain in patients having mastectomy surgery
  • Outline alternative approaches of breast reconstruction using tissue expanders or implants
  • Review recent clinical data for immune therapy in breast cancer and describe future directions
  • Discuss current data for accelerated partial breast irradiation and describe new and emerging techniques
  • Present available data regarding risk factors and selection of patients for omission of radiation after lumpectomy and discuss ongoing trials addressing this issue
  • Decribe the rationale for pre-operative systemic therapy for breast cancer and to formulate individualized treatment and monitoring plans
  • Review biological and clinical trial evidence in the optimal management of advanced HER2-positive breast cancer
  • Outline options for management of DCIS for imaging, pathology, surgery, reconstruction, and other issues
  • Review controversies surrounding breast cancer screening